Roy C. Hardiman Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Roy C. Hardiman.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Roy C. Hardiman. Roy C. Hardiman is Director in PHARMACYCLICS INC ($PCYC) and Chief Business Officer in Principia Biopharma Inc. ($PRNB).
Latest Insider Trading Transactions of Roy C. Hardiman
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 28 2020 | PRNB | Principia Biopharm ... | Hardiman Roy C. | Chief Business Offi ... | Option Exercise | D | 67.31 | 55,000 | 3,702,050 | 0 | |
| Sep 28 2020 | PRNB | Principia Biopharm ... | Hardiman Roy C. | Chief Business Offi ... | Option Exercise | D | 35.42 | 60,000 | 2,125,200 | 0 | |
| Sep 28 2020 | PRNB | Principia Biopharm ... | Hardiman Roy C. | Chief Business Offi ... | Option Exercise | D | 11.35 | 44,034 | 500,002 | 0 | |
| Sep 28 2020 | PRNB | Principia Biopharm ... | Hardiman Roy C. | Chief Business Offi ... | Option Exercise | D | 7.27 | 11,519 | 83,710 | 0 | |
| Sep 28 2020 | PRNB | Principia Biopharm ... | Hardiman Roy C. | Chief Business Offi ... | Sell | U | 100.00 | 1,916 | 191,600 | 0 | 1.9 K to 0 (-100.00 %) |
| Sep 28 2020 | PRNB | Principia Biopharm ... | Hardiman Roy C. | Chief Business Offi ... | Sell | U | 100.00 | 117,761 | 11,776,100 | 0 | 117.8 K to 0 (-100.00 %) |
| Sep 22 2020 | PRNB | Principia Biopharm ... | Hardiman Roy C. | Chief Business Offi ... | Option Exercise | M | 7.27 | 2,242 | 16,293 | 11,519 | |
| Sep 22 2020 | PRNB | Principia Biopharm ... | Hardiman Roy C. | Chief Business Offi ... | Option Exercise | M | 4.72 | 2,758 | 13,028 | 0 | |
| Sep 22 2020 | PRNB | Principia Biopharm ... | Hardiman Roy C. | Chief Business Offi ... | Sell | S | 99.98 | 5,000 | 499,918 | 117,761 | 122.8 K to 117.8 K (-4.07 %) |
| Sep 22 2020 | PRNB | Principia Biopharm ... | Hardiman Roy C. | Chief Business Offi ... | Buy | M | 7.27 | 2,242 | 16,293 | 122,761 | 120.5 K to 122.8 K (+1.86 %) |
| Sep 22 2020 | PRNB | Principia Biopharm ... | Hardiman Roy C. | Chief Business Offi ... | Buy | M | 4.72 | 2,758 | 13,028 | 120,519 | 117.8 K to 120.5 K (+2.34 %) |
| Jun 15 2020 | PRNB | Principia Biopharm ... | Hardiman Roy C. | Chief Business Offi ... | Option Exercise | M | 4.72 | 5,000 | 23,618 | 2,758 | |
| Jun 15 2020 | PRNB | Principia Biopharm ... | Hardiman Roy C. | Chief Business Offi ... | Sell | S | 62.13 | 863 | 53,617 | 117,761 | 118.6 K to 117.8 K (-0.73 %) |
| Jun 15 2020 | PRNB | Principia Biopharm ... | Hardiman Roy C. | Chief Business Offi ... | Sell | S | 61.62 | 2,542 | 156,630 | 118,624 | 121.2 K to 118.6 K (-2.10 %) |
| Jun 15 2020 | PRNB | Principia Biopharm ... | Hardiman Roy C. | Chief Business Offi ... | Sell | S | 59.90 | 1,595 | 95,541 | 121,166 | 122.8 K to 121.2 K (-1.30 %) |
| Jun 15 2020 | PRNB | Principia Biopharm ... | Hardiman Roy C. | Chief Business Offi ... | Buy | M | 4.72 | 5,000 | 23,618 | 122,761 | 117.8 K to 122.8 K (+4.25 %) |
| Mar 17 2020 | PRNB | Principia Biopharm ... | Hardiman Roy C. | Chief Business Offi ... | Option Exercise | M | 4.72 | 5,000 | 23,618 | 7,758 | |
| Mar 17 2020 | PRNB | Principia Biopharm ... | Hardiman Roy C. | Chief Business Offi ... | Sell | S | 51.04 | 100 | 5,104 | 116,903 | 117 K to 116.9 K (-0.09 %) |
| Mar 17 2020 | PRNB | Principia Biopharm ... | Hardiman Roy C. | Chief Business Offi ... | Sell | S | 49.46 | 1,181 | 58,408 | 117,003 | 118.2 K to 117 K (-1.00 %) |
| Mar 17 2020 | PRNB | Principia Biopharm ... | Hardiman Roy C. | Chief Business Offi ... | Sell | S | 48.21 | 3,719 | 179,304 | 118,184 | 121.9 K to 118.2 K (-3.05 %) |
| Mar 17 2020 | PRNB | Principia Biopharm ... | Hardiman Roy C. | Chief Business Offi ... | Buy | M | 4.72 | 5,000 | 23,618 | 121,903 | 116.9 K to 121.9 K (+4.28 %) |
| Mar 05 2020 | PRNB | Principia Biopharm ... | Hardiman Roy C. | Chief Business Offi ... | Option Exercise | A | 67.31 | 55,000 | 3,702,050 | 55,000 | |
| Dec 13 2019 | PRNB | Principia Biopharm ... | Hardiman Roy C. | Chief Business Offi ... | Option Exercise | M | 5.00 | 4,129 | 20,629 | 0 | |
| Dec 13 2019 | PRNB | Principia Biopharm ... | Hardiman Roy C. | Chief Business Offi ... | Option Exercise | M | 5.00 | 4,129 | 20,629 | 0 | |
| Dec 13 2019 | PRNB | Principia Biopharm ... | Hardiman Roy C. | Chief Business Offi ... | Option Exercise | M | 4.72 | 871 | 4,114 | 12,758 | |
| Dec 13 2019 | PRNB | Principia Biopharm ... | Hardiman Roy C. | Chief Business Offi ... | Option Exercise | M | 4.72 | 871 | 4,114 | 12,758 | |
| Dec 13 2019 | PRNB | Principia Biopharm ... | Hardiman Roy C. | Chief Business Offi ... | Sell | S | 49.83 | 1,619 | 80,682 | 120,143 | 121.8 K to 120.1 K (-1.33 %) |
| Dec 13 2019 | PRNB | Principia Biopharm ... | Hardiman Roy C. | Chief Business Offi ... | Sell | S | 49.83 | 1,619 | 80,682 | 120,143 | 121.8 K to 120.1 K (-1.33 %) |
| Dec 13 2019 | PRNB | Principia Biopharm ... | Hardiman Roy C. | Chief Business Offi ... | Sell | S | 49.20 | 3,381 | 166,352 | 121,762 | 125.1 K to 121.8 K (-2.70 %) |
| Dec 13 2019 | PRNB | Principia Biopharm ... | Hardiman Roy C. | Chief Business Offi ... | Sell | S | 49.20 | 3,381 | 166,352 | 121,762 | 125.1 K to 121.8 K (-2.70 %) |
| Dec 13 2019 | PRNB | Principia Biopharm ... | Hardiman Roy C. | Chief Business Offi ... | Buy | M | 5.00 | 4,129 | 20,629 | 125,143 | 121 K to 125.1 K (+3.41 %) |
| Dec 13 2019 | PRNB | Principia Biopharm ... | Hardiman Roy C. | Chief Business Offi ... | Buy | M | 5.00 | 4,129 | 20,629 | 125,143 | 121 K to 125.1 K (+3.41 %) |
| Dec 13 2019 | PRNB | Principia Biopharm ... | Hardiman Roy C. | Chief Business Offi ... | Buy | M | 4.72 | 871 | 4,114 | 121,014 | 120.1 K to 121 K (+0.72 %) |
| Dec 13 2019 | PRNB | Principia Biopharm ... | Hardiman Roy C. | Chief Business Offi ... | Buy | M | 4.72 | 871 | 4,114 | 121,014 | 120.1 K to 121 K (+0.72 %) |
| Mar 08 2019 | PRNB | Principia Biopharm ... | Hardiman Roy C. | Chief Business Offi ... | Option Exercise | A | 35.42 | 60,000 | 2,125,200 | 60,000 | |
| Dec 13 2010 | PCYC | PHARMACYCLICS INC | Hardiman Roy C. | Director | Option Exercise | A | 5.81 | 20,000 | 116,200 | 20,000 | |
| Dec 13 2010 | PCYC | PHARMACYCLICS INC | Hardiman Roy C. | Director | Option Exercise | A | 5.76 | 10,000 | 57,600 | 10,000 |
Page: 1